Jayakrishnan, T.; Aulakh, S.; Baksh, M.; Nguyen, K.; Ailawadhi, M.; Samreen, A.; Parrondo, R.; Sher, T.; Roy, V.; Manochakian, R.;
et al. Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting. Cancers 2021, 13, 5770.
https://doi.org/10.3390/cancers13225770
AMA Style
Jayakrishnan T, Aulakh S, Baksh M, Nguyen K, Ailawadhi M, Samreen A, Parrondo R, Sher T, Roy V, Manochakian R,
et al. Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting. Cancers. 2021; 13(22):5770.
https://doi.org/10.3390/cancers13225770
Chicago/Turabian Style
Jayakrishnan, Thejus, Sonikpreet Aulakh, Mizba Baksh, Kianna Nguyen, Meghna Ailawadhi, Ayesha Samreen, Ricardo Parrondo, Taimur Sher, Vivek Roy, Rami Manochakian,
and et al. 2021. "Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting" Cancers 13, no. 22: 5770.
https://doi.org/10.3390/cancers13225770
APA Style
Jayakrishnan, T., Aulakh, S., Baksh, M., Nguyen, K., Ailawadhi, M., Samreen, A., Parrondo, R., Sher, T., Roy, V., Manochakian, R., Paulus, A., Chanan-Khan, A., & Ailawadhi, S.
(2021). Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting. Cancers, 13(22), 5770.
https://doi.org/10.3390/cancers13225770
